FSH administration at 12-hour intervals for the first 2 days, combined with mandatory GnRH-agonist trigger and blastocyst vitrification in women (<80Kg) with high AMH levels, results in higher cumulative live birth rates and is safer

References

• Abbara, A., Clarke, S., Islam, R., Prague, J. K., Comninos, A. N., Narayanaswamy, S., Papadopoulou, D., Roberts, R., Izzi-Engbeaya, C., Ratnasabapathy, R., Nesbitt, A., Vimalesvaran, S., Salim, R., Lavery, S. A., Bloom, S. R., Huson, L., Trew, G. H., & Dhillo, W. S. (2017). A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: A Phase 2 randomized controlled trial. Human Reproduction, 32(9), 1915–1924. https://doi.org/10.1093/humrep/dex253
   PubMed Web of Science ®Google Scholar
• Babayof, R., Margalioth, E. J., Huleihel, M., Amash, A., Zylber-Haran, E., Gal, M., Brooks, B., Mimoni, T., & Eldar-Geva, T. (2006). Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: A prospective randomized trial. Human Reproduction, 21(5), 1260–1265. https://doi.org/10.1093/humrep/dei475
   PubMed Web of Science ®Google Scholar
• Castillo, J. C., Haahr, T., Martínez-Moya, M., & Humaidan, P. (2020). Gonadotropin-releasing hormone agonist for ovulation trigger – OHSS prevention and use of modified luteal phase support for fresh embryo transfer. Upsala Journal of Medical Sciences, 125(2), 131–137. https://doi.org/10.1080/03009734.2020.1736696
   PubMed Web of Science ®Google Scholar
• Chen, Z.-J., Shi, Y., Sun, Y., Zhang, B., Liang, X., Cao, Y., Yang, J., Liu, J., Wei, D., Weng, N., Tian, L., Hao, C., Yang, D., Zhou, F., Shi, J., Xu, Y., Li, J., Yan, J., Qin, Y., … Legro, R. S. (2016). Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. The New England Journal of Medicine, 375(6), 523–533. https://doi.org/10.1056/NEJMoa1513873
   PubMed Web of Science ®Google Scholar
• Humaidan, P., Papanikolaou, E. G., & Tarlatzis, B. C. (2009). GnRHa to trigger final oocyte maturation: A time to reconsider. Human Reproduction, 24(10), 2389–2394. https://doi.org/10.1093/humrep/dep246
   PubMed Web of Science ®Google Scholar
• La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010). Anti-müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Human Reproduction Update, 16(2), 113–130. https://doi.org/10.1093/humupd/dmp036
   PubMed Web of Science ®Google Scholar
• Le Contonnec, J. Y., Porchet, H. C., Beltrami, V., Khan, A., Toon, S., & Rowland, M. (1994). Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady-state pharmacokinetics. Fertility and Sterility, 61(4), 679–686. https://doi.org/10.1016/S0015-0282(16)56645-X
   PubMed Web of Science ®Google Scholar
• Mascarenhas, M., & Balen, A. H. (2017). The high responder: A review of pathophysiology and outcomes during IVF treatment. Human Fertility, 20(3), 155–167. https://doi.org/10.1080/14647273.2017.1293851
   PubMed Web of Science ®Google Scholar
• Nargund, G., Datta, A. K., & Fauser, B. (2017). Mild stimulation for in vitro fertilization. Fertility and Sterility, 108(4), 558–567. https://doi.org/10.1016/j.fertnstert.2017.08.022
   PubMed Web of Science ®Google Scholar
• Nelson, S. M., Yates, R. W., & Fleming, R. (2007). Serum anti-müllerian hormone and FSH: Prediction of live birth and extremes of response in stimulated cycles–implications for individualization of therapy. Human Reproduction, 22(9), 2414–2421. https://doi.org/10.1093/humrep/dem204
   PubMed Web of Science ®Google Scholar
• Nelson, S. M., Yates, R. W., Lyall, H., Jamieson, M., Traynor, I., Gaudoin, M., Mitchell, P., Ambrose, P., & Fleming, R. (2009). Anti-müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Human Reproduction, 24(4), 867–875. https://doi.org/10.1093/humrep/den480
   PubMed Web of Science ®Google Scholar
• Nyboe Andersen, A., Nelson, S. M., Fauser, B. C., García-Velasco, J. A., Klein, B. M., & Arce, J. C. (2017). Individualized versus conventional ovarian stimulation for in vitro fertilization: A multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertility and Sterility, 107(2), 387–396.e4. https://doi.org/10.1016/j.fertnstert.2016.10.033
   PubMed Web of Science ®Google Scholar
• Porchet, H. C., Le Cotonnec, J. Y., & Loumaye, E. (1994). Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration. Fertility and Sterility, 61(4), 687–695. https://doi.org/10.1016/S0015-0282(16)56646-1
   PubMed Web of Science ®Google Scholar
• Roque, M., Haahr, T., Geber, S., Esteves, S. C., & Humaidan, P. (2019). Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: A systematic review and meta-analysis of reproductive outcomes. Human Reproduction Update, 25(1), 2–14. https://doi.org/10.1093/humupd/dmy033
   PubMed Web of Science ®Google Scholar
• Sallam, H. N., Ezzeldin, F., Agameya, A. F., Rahman, A. F., & El-Garem, Y. (2005). Defining poor responders in assisted reproduction. International Journal of Fertility and Women’s Medicine, 50(3), 115–120.
   PubMedGoogle Scholar
• Shi, Y., Sun, Y., Hao, C., Zhang, H., Wei, D., Zhang, Y., Zhu, Y., Deng, X., Qi, X., Li, H., Ma, X., Ren, H., Wang, Y., Zhang, D., Wang, B., Liu, F., Wu, Q., Wang, Z., Bai, H., … Chen, Z.-J. (2018). Transfer of fresh versus frozen embryos in ovulatory women. The New England Journal of Medicine, 378(2), 126–136. https://doi.org/10.1056/NEJMoa1705334
   PubMed Web of Science ®Google Scholar
• Smith, A., Tilling, K., Lawlor, D. A., & Nelson, S. M. (2019). Live birth rates and perinatal outcomes when all embryos are frozen compared with conventional fresh and frozen embryo transfer: A cohort study of 337,148 in vitro fertilisation cycles. BMC Medicine, 17(1), 202. https://doi.org/10.1186/s12916-019-1429-z
   PubMed Web of Science ®Google Scholar
• Sunkara, S. K., Rittenberg, V., Raine-Fenning, N., Bhattacharya, S., Zamora, J., & Coomarasamy, A. (2011). Association between the number of eggs and live birth in IVF treatment: An analysis of 400 135 treatment cycles. Human Reproduction, 26(7), 1768–1774. https://doi.org/10.1093/humrep/der106
   PubMed Web of Science ®Google Scholar
• The ESHRE Guideline Group On Ovarian Stimulation, Bosch, E., Broer, S., Griesinger, G., Grynberg, M., Humaidan, P., Kolibianakis, E., Kunicki, M., La Marca, A., Lainas, G., Le Clef, N., Massin, N., Mastenbroek, S., Polyzos, N., Sunkara, S. K., Timeva, T., Töyli, M., Urbancsek, J., Vermeulen, N., & Broekmans, F, (2020). ESHRE guideline: Ovarian stimulation for IVF/ICSI. Human Reproduction Open, 2020(2), hoaa009. https://doi.org/10.1093/hropen/hoaa009
   PubMedGoogle Scholar
• Wei, D., Liu, J.-Y., Sun, Y., Shi, Y., Zhang, B., Liu, J.-Q., Tan, J., Liang, X., Cao, Y., Wang, Z., Qin, Y., Zhao, H., Zhou, Y., Ren, H., Hao, G., Ling, X., Zhao, J., Zhang, Y., Qi, X., … Chen, Z.-J. (2019). Frozen versus fresh single blastocyst transfer in ovulatory women: A multicentre, randomised controlled trial. Lancet, 393(10178), 1310–1318. https://doi.org/10.1016/S0140-6736(18)32843-5
   PubMed Web of Science ®Google Scholar